References
- Rodeghiero F., Avvisati G., Castaman G., Barbui T., Mandelli F. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 1990; 75: 2112–2107
- Kantarjian H. M., Keating M. J., Walters R. S., Estey E. H., McCredie K. B., Smith T., Dalton W., Cork A., Trujillo J. M., Freireich E. J. Acute promyelocytic leukemia. M.D. Anderson Hospital experience. Am. J. Med. 1986; 80: 789–797
- Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–1709
- Tallman M. S., Kwaan H. C. Reassessing the hemostatic disorder associated with acute promylocytic leukemia. Blood 1992; 79: 543–553
- Bassan R., Battista R., D'Emilio A., Viero P., Dragone P., Dini E., Barbui T. Long-term results of the HEAVD protocol for adult acute lymphoblastic leukemia. Eur. J. Cancer 1991; 27: 441–447
- Rohatiner A. 2. S., Bassan R., Battista R., Barnett M. J., Gregory W., Lim J., Amess J., Oza A., Barbui T., Horton M., Chisesi T., Lister T. A. High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukemia. Br. J. Cancer 1990; 62: 454–458
- Bassan R., Battista R., Rohatiner A. Z. S., Love S., Carter M., Buelli M., Viero P., D'Emilio A., MacCallum P., Amess J., Dini E., Barbui T., Lister T. A. Treatment of adult acute lymphoblastic leukemia (ALL) over a 16 year period. Leukemia 1992; 6(Suppl. 2)186–190
- Bassan R., Battista R., Corneo G., Rossi G., Lamber-tenghi-Deliliers G., Viero P., Rambaldi A., D'Emilio A., Neonato M. G., Pogliani E., Oriani A., Izzi T., Dini E., Barbui T. Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome. Leukemia and Lymphoma 1993, (in press)
- Hoelzer D., Thiel E., Loffler H., Bodenstein H., Plau-Mann L., Buchner T., Urbanitz D., Koch P., Heimpel H., Engelhardt R., Muller U., Wendt F.C., Sodomann H., Ruhl H., Henmann F., Kaboth W., Dietzfelbinger H., Pralle H., Lunscken Ch., Hellriegel K.P., Spors S., No-Wrousian R. M., Fischer J., Fulle H., Mitrou P. S., Pfreundschuh M., Gorg Ch., Emmerich B., Queisser W., Meyer P., Labedzki L., Essers U., Konig H., Mainzer K., Hemnann R., Messerer D., Zwingers T. Intensified therapy in acute lymphoblastic and acute undif-ferentiated leukemia in adults. Blood 1984; 64: 38–47
- Sams A. H., Kempin S., Berman E., Michaeli J., Little C., Andreeff M., Gee T., Straus D., Gansbacher B., Filippa D., Glaser B., Clarkson B. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood 1992; 79: 1305–1310
- Falanga A., Alessio M. G., Donati M. B., Barbui T. A new procoagulant in acute leukemia. Blood 1988; 71: 870–875
- Alessio M. G., Falanga A., Consonni R., Bassan R., Mi-Netti B., Donati M. B., Barbui T. Eur. J. Hae-matol. 1990; 45: 78–81
- Gordon S. G., Marlar R., Madden R., Falanga A. Inactivation of the Protein C system by cancer procoagulant. Thromb. Haemost. 1989; 62(1)40, abstr.
- Barbui T., Finazzi G., Donati M. B., Falanga A. Antiblastic therapy and thrombosis. Thrombosis. An up date, G. G. Neri Serneri, G. F. Gensini, R. Abbate, D. Prisco. Scientific Press, Florence 1992; 305–314
- Pui C.H., Jackson C. W., Chesney C. M., Abildgaard C. F. Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia. Am. J. Hematol. 1987; 25: 291–298
- Gugliotta L., D'Angelo A., Mattioli-Belmonte M., Viganò-D'Angelo S., Colomho G., Catani L., Gianni L., Lauria F., Tura S. Hypercoagulability during L-aspara-ginase treatment: the effect of antithrombin III supplementation in vivo. Br. J. Haematol. 1990; 74: 465–470
- Finazzi G., Buelli M., Minetti B., Caccia R., Barbui T. Anticoagulant therapy for cerebral vein thrombosis in four adult patients with acute lymphoblastic leukemia. Blood 1989; 74(Suppl. l)356a, abstr.